Pfizer’s annual revenue is expected to reach $101.3 billion in 2022, thanks to its COVID jab, which doesn’t prevent infection or spread.
- Pfizer’s annual revenue is expected to reach $101.3 billion in 2022, thanks to its COVID jab, which doesn’t prevent infection or spread, and Paxlovid, an ineffective and dangerous COVID antiviral that causes rebound
- Pfizer got plenty of free help from the federal government, which bullied and harassed people into getting the shots, and implemented rules that ensure hospitals and pharmacies will only prescribe certain COVID drugs, Paxlovid being one of them
- The key to getting away with a really big lie is making it so divorced from reality that the listener will assume their own perception is flawed, and then repeating it over and over again. This strategy has been used to great effect over the past three years, resulting in a massive shift from fact-based public health orthodoxy to irrational fantasy-based dogma
- Centralized top-down health care is far more attractive to Big Pharma investors than patient-centered care. The primary obstacle to the corporatization and monetization of public health has been truth, and this obstacle was finally overcome during the COVID pandemic
- The Big Lies told during the pandemic work because they veer so sharply from the truth. This break from factual reality is what makes it so difficult to question them, because if you do, you’re now questioning the entire hierarchy of public health
The manufactured COVID pandemic has been a proverbial golden egg-laying goose for Pfizer. Its annual revenue is expected to reach $101.3 billion in 2022,1Fierce Pharma November 21, 2021 thanks to its COVID jab, which doesn’t prevent infection or spread, and Paxlovid, an ineffective and dangerous COVID antiviral that causes rebound. It would be comical if it weren’t so egregious.
Keep reading with a private membership…
Subscribe to keep reading this article and access all article archives. See membership options.
Already a paid subscriber? Sign in.